The document describes a customized Pipeline Pilot web portal developed for SP Intervets to replace their former bioinformatics software. The portal was designed to meet requirements for usability for non-specialists and functionality for experts. It integrates bioinformatics protocols and tools into a user-friendly interface that stores results in a user context rather than job context. Examples demonstrate running BLAST searches, viewing and refining results, and generating PDF reports. The portal provides flexible access to databases and allows updating and extending functionality. It has successfully replaced the former application framework.
Presentation given at the Federal Environment Symposium on March 28th 2022.
As part of its mission the Center for Computational Toxicology and Exposure (CCTE) delivers access to chemicals related data via online Dashboards. The CompTox Chemicals Dashboard (available at https://comptox.epa.gov/dashboard) provides access to >900,000 chemicals and associated data including experimental and predicted property data, in vivo hazard data, in vitro bioactivity data, exposure data, and various other data types. The application provides a set of flexible searches allowing for search, visualization and downloads of the data to the desktop for further interrogation. This presentation will provide an overview of the Dashboard and other proof-of-concept applications. For example, the Hazard Comparison Dashboard has a module which allows profiling of chemicals based on toxicity types (https://doi.org/10.1007/s10098-019-01795-w). This presentation will also introduce a number of proof-of-concept modules in development. This abstract does not necessarily represent the views or policies of the U.S. Environmental Protection Agency.
Alex M. Clark, CINF, ACS 2012 PhiladelphiaAlex Clark
Presentation at the American Chemical Society meeting (Philadelphia, 2012) by Alex M. Clark from Molecular Materials Informatics, Inc. Mobile apps participating in open science, both content creation and consumption.
FAIR Data and Model Management for Systems Biology(and SOPs too!)Carole Goble
MultiScale Biology Network Springboard meeting, Nottingham, UK, 1 June 2015
FAIR Data and model management for Systems Biology
Over the past 5 years we have seen a change in expectations for the management of all the outcomes of research – that is the “assets” of data, models, codes, SOPs and so forth. Don’t stop reading. Yes, data management isn’t likely to win anyone a Nobel prize. But publications should be supported and accompanied by data, methods, procedures, etc. to assure reproducibility of results. Funding agencies expect data (and increasingly software) management retention and access plans as part of the proposal process for projects to be funded. Journals are raising their expectations of the availability of data and codes for pre- and post- publication. And the multi-component, multi-disciplinary nature of Systems Biology demands the interlinking and exchange of assets and the systematic recording of metadata for their interpretation.
Data and model management for the Systems Biology community is a multi-faceted one including: the development and adoption appropriate community standards (and the navigation of the standards maze); the sustaining of international public archives capable of servicing quantitative biology; and the development of the necessary tools and know-how for researchers within their own institutes so that they can steward their assets in a sustainable, coherent and credited manner while minimizing burden and maximising personal benefit.
The FAIRDOM (Findable, Accessible, Interoperable, Reusable Data, Operations and Models) Initiative has grown out of several efforts in European programmes (SysMO and EraSysAPP ERANets and the ISBE ESRFI) and national initiatives (de.NBI, German Virtual Liver Network, SystemsX, UK SynBio centres). It aims to support Systems Biology researchers with data and model management, with an emphasis on standards smuggled in by stealth.
This talk will use the FAIRDOM Initiative to discuss the FAIR management of data, SOPs, and models for Sys Bio, highlighting the challenges multi-scale biology presents.
http://www.fair-dom.org
http://www.fairdomhub.org
http://www.seek4science.org
Laboratories around the world continue to generate immense amounts of data that are non-proprietary and of value to the community. If available these data could dramatically reduce costs by minimizing rework and ultimately facilitating faster research. High quality reference data collections of chemical compound dictionaries, properties and spectra have been generated over many decades. With the advent of social networking tools and platforms such as Wikipedia, the community has an opportunity to contribute. The ChemSpider platform hosted by the Royal Society of Chemistry is a compound centric database with associated data. Already populated with almost 25 million unique compounds the community can deposit and host their own data, and curate and annotate existing data including those generated in Open Notebook Science Efforts. This presentation will provide an overview of progress to date and outline the vision of this community platform for chemistry and ensuring the longevity of chemistry reference data.
Written and presented by Tom Ingraham (F1000), at the Reproducible and Citable Data and Model Workshop, in Warnemünde, Germany. September 14th -16th 2015.
Presentation given at the Federal Environment Symposium on March 28th 2022.
As part of its mission the Center for Computational Toxicology and Exposure (CCTE) delivers access to chemicals related data via online Dashboards. The CompTox Chemicals Dashboard (available at https://comptox.epa.gov/dashboard) provides access to >900,000 chemicals and associated data including experimental and predicted property data, in vivo hazard data, in vitro bioactivity data, exposure data, and various other data types. The application provides a set of flexible searches allowing for search, visualization and downloads of the data to the desktop for further interrogation. This presentation will provide an overview of the Dashboard and other proof-of-concept applications. For example, the Hazard Comparison Dashboard has a module which allows profiling of chemicals based on toxicity types (https://doi.org/10.1007/s10098-019-01795-w). This presentation will also introduce a number of proof-of-concept modules in development. This abstract does not necessarily represent the views or policies of the U.S. Environmental Protection Agency.
Alex M. Clark, CINF, ACS 2012 PhiladelphiaAlex Clark
Presentation at the American Chemical Society meeting (Philadelphia, 2012) by Alex M. Clark from Molecular Materials Informatics, Inc. Mobile apps participating in open science, both content creation and consumption.
FAIR Data and Model Management for Systems Biology(and SOPs too!)Carole Goble
MultiScale Biology Network Springboard meeting, Nottingham, UK, 1 June 2015
FAIR Data and model management for Systems Biology
Over the past 5 years we have seen a change in expectations for the management of all the outcomes of research – that is the “assets” of data, models, codes, SOPs and so forth. Don’t stop reading. Yes, data management isn’t likely to win anyone a Nobel prize. But publications should be supported and accompanied by data, methods, procedures, etc. to assure reproducibility of results. Funding agencies expect data (and increasingly software) management retention and access plans as part of the proposal process for projects to be funded. Journals are raising their expectations of the availability of data and codes for pre- and post- publication. And the multi-component, multi-disciplinary nature of Systems Biology demands the interlinking and exchange of assets and the systematic recording of metadata for their interpretation.
Data and model management for the Systems Biology community is a multi-faceted one including: the development and adoption appropriate community standards (and the navigation of the standards maze); the sustaining of international public archives capable of servicing quantitative biology; and the development of the necessary tools and know-how for researchers within their own institutes so that they can steward their assets in a sustainable, coherent and credited manner while minimizing burden and maximising personal benefit.
The FAIRDOM (Findable, Accessible, Interoperable, Reusable Data, Operations and Models) Initiative has grown out of several efforts in European programmes (SysMO and EraSysAPP ERANets and the ISBE ESRFI) and national initiatives (de.NBI, German Virtual Liver Network, SystemsX, UK SynBio centres). It aims to support Systems Biology researchers with data and model management, with an emphasis on standards smuggled in by stealth.
This talk will use the FAIRDOM Initiative to discuss the FAIR management of data, SOPs, and models for Sys Bio, highlighting the challenges multi-scale biology presents.
http://www.fair-dom.org
http://www.fairdomhub.org
http://www.seek4science.org
Laboratories around the world continue to generate immense amounts of data that are non-proprietary and of value to the community. If available these data could dramatically reduce costs by minimizing rework and ultimately facilitating faster research. High quality reference data collections of chemical compound dictionaries, properties and spectra have been generated over many decades. With the advent of social networking tools and platforms such as Wikipedia, the community has an opportunity to contribute. The ChemSpider platform hosted by the Royal Society of Chemistry is a compound centric database with associated data. Already populated with almost 25 million unique compounds the community can deposit and host their own data, and curate and annotate existing data including those generated in Open Notebook Science Efforts. This presentation will provide an overview of progress to date and outline the vision of this community platform for chemistry and ensuring the longevity of chemistry reference data.
Written and presented by Tom Ingraham (F1000), at the Reproducible and Citable Data and Model Workshop, in Warnemünde, Germany. September 14th -16th 2015.
The US EPA’s CompTox Chemistry Dashboard provides access to various types of data associated with ~760,000 chemical substances. These data include experimental and predicted property data, high-throughput screening assay data and hazard and environmental exposure data. With millions of individual data points and annotations associated with hundreds of thousands of chemicals, data quality is a priority. With tens of thousands of individual users per month browsing the data on the dashboard, the ability of users to provide feedback has allowed us to identify, confirm and address issues in the data. This has required the implementation of novel approaches for data feedback via the user interface that include general feedback on the dashboard and down to individual data points contained in a table. We are presently investigating ways to garner feedback on our ToxCast bioassay data to facilitate the curation of tens of thousands of data points. This presentation will provide an overview of our existing capabilities in the CompTox Chemistry Dashboard for gathering crowdsourced data from the user base and its impact on assisting in the curation of data.
This abstract does not necessarily represent the views or policies of the U.S. Environmental Protection Agency.
This presentation was provided by Paul Needham of Cranfield University and Johan Bollen of Indiana University, during the NISO webinar "Measuring Use, Assessing Success, Part Two: Count Me In: Measuring Individual Item Usage," which was held on September 15, 2010.
EUGM 2014 - Marco Brazzarola (Aptuit): Aptuit Compound Registration and Inte...ChemAxon
Aptuit Verona transitioned from a former Pharma R&D Center to an integrated Contracting Discovery & Development Organization (CDDO). This presentation will describe how we collaborated with ChemAxon and adopted their platform to implement a Compound Registration system, integrated within our Discovery Data Management ecosystem. It will highlight the benefits of ChemAxon model and toolkit for companies like Aptuit, needing rapid/agile responses to evolving business needs.
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...Dr. Haxel Consult
The pressures of pharmaceutical research and development demand increasing efficiency from scientists. High-quality decisions must be made faster and encompass all available information. At the same time there is a growing desire to better utilize the multi-billion dollar research investment recorded in laboratory notebooks and bioassay databases. Key values for data integration in a data exploration environment include gathering data from disparate E-notebooks and bioassay databases into a single searchable “virtual” system and increased discoverability by accessing data through a system designed for exploration. Key benefits are better chemistry decisions through easier access to broader data and reduced time for preparing patent filings. The ability to interlink in-house and reported assay data with in-house and published chemistry provides a data-rich environment for developing insights and predictive models. We will discuss our experience with integrating information from journals, patents, bio-assay databases, and E-lab notebooks to address these needs.
Revolutionizing Laboratory Instrument Data for the Pharmaceutical Industry:...OSTHUS
The Allotrope Foundation is a consortium of major pharmaceutical companies and a partner network whose goal is to address challenges in the pharmaceutical industry by providing a set of public, non-proprietary standards for using and integrating analytical laboratory data. Current challenges in data management within the pharmaceutical industry often center around inconsistent or incomplete data and metadata and proprietary data formats. Because of a lack of standardization, several operations (e.g. integration of instruments/applications, transfer of methods or results, archiving for regulatory purposes) require unnecessary efforts. Further, higher level aggregation of data, e.g. regulatory filings, that are derived from multiple sources of laboratory data are costly to create. These unnecessary costs impact operations within a company’s laboratories, between partnering companies, and between a company and contract research organizations (CROs). Finally, the accelerating transition of laboratories from hybrid (paper + electronic) to purely electronic data streams, coupled with an ever-increasing regulatory scrutiny of electronic data management practices, further require a comprehensive solution. This talk will discuss how The Allotrope Foundation is providing a new framework for data standards through collaboration between numerous stakeholders.
The US EPA’s CompTox Chemistry Dashboard provides access to various types of data associated with ~760,000 chemical substances. These data include experimental and predicted property data, high-throughput screening assay data and hazard and environmental exposure data. With millions of individual data points and annotations associated with hundreds of thousands of chemicals, data quality is a priority. With tens of thousands of individual users per month browsing the data on the dashboard, the ability of users to provide feedback has allowed us to identify, confirm and address issues in the data. This has required the implementation of novel approaches for data feedback via the user interface that include general feedback on the dashboard and down to individual data points contained in a table. We are presently investigating ways to garner feedback on our ToxCast bioassay data to facilitate the curation of tens of thousands of data points. This presentation will provide an overview of our existing capabilities in the CompTox Chemistry Dashboard for gathering crowdsourced data from the user base and its impact on assisting in the curation of data.
This abstract does not necessarily represent the views or policies of the U.S. Environmental Protection Agency.
This presentation was provided by Paul Needham of Cranfield University and Johan Bollen of Indiana University, during the NISO webinar "Measuring Use, Assessing Success, Part Two: Count Me In: Measuring Individual Item Usage," which was held on September 15, 2010.
EUGM 2014 - Marco Brazzarola (Aptuit): Aptuit Compound Registration and Inte...ChemAxon
Aptuit Verona transitioned from a former Pharma R&D Center to an integrated Contracting Discovery & Development Organization (CDDO). This presentation will describe how we collaborated with ChemAxon and adopted their platform to implement a Compound Registration system, integrated within our Discovery Data Management ecosystem. It will highlight the benefits of ChemAxon model and toolkit for companies like Aptuit, needing rapid/agile responses to evolving business needs.
ICIC 2014 Increasing the efficiency of pharmaceutical research through data i...Dr. Haxel Consult
The pressures of pharmaceutical research and development demand increasing efficiency from scientists. High-quality decisions must be made faster and encompass all available information. At the same time there is a growing desire to better utilize the multi-billion dollar research investment recorded in laboratory notebooks and bioassay databases. Key values for data integration in a data exploration environment include gathering data from disparate E-notebooks and bioassay databases into a single searchable “virtual” system and increased discoverability by accessing data through a system designed for exploration. Key benefits are better chemistry decisions through easier access to broader data and reduced time for preparing patent filings. The ability to interlink in-house and reported assay data with in-house and published chemistry provides a data-rich environment for developing insights and predictive models. We will discuss our experience with integrating information from journals, patents, bio-assay databases, and E-lab notebooks to address these needs.
Revolutionizing Laboratory Instrument Data for the Pharmaceutical Industry:...OSTHUS
The Allotrope Foundation is a consortium of major pharmaceutical companies and a partner network whose goal is to address challenges in the pharmaceutical industry by providing a set of public, non-proprietary standards for using and integrating analytical laboratory data. Current challenges in data management within the pharmaceutical industry often center around inconsistent or incomplete data and metadata and proprietary data formats. Because of a lack of standardization, several operations (e.g. integration of instruments/applications, transfer of methods or results, archiving for regulatory purposes) require unnecessary efforts. Further, higher level aggregation of data, e.g. regulatory filings, that are derived from multiple sources of laboratory data are costly to create. These unnecessary costs impact operations within a company’s laboratories, between partnering companies, and between a company and contract research organizations (CROs). Finally, the accelerating transition of laboratories from hybrid (paper + electronic) to purely electronic data streams, coupled with an ever-increasing regulatory scrutiny of electronic data management practices, further require a comprehensive solution. This talk will discuss how The Allotrope Foundation is providing a new framework for data standards through collaboration between numerous stakeholders.
Pre-Integrated Volume-Rendering with Randomized Transfer-Functions (V3D2 Work...Frank Oellien
Usage of volume rendering techniques in Chemitry and Medicine
V3D2 Workshop 2002, Braunschweig,
Strategic DFG research initiative "V3D2" ("Distributed Processing and Exchange of Digital Documents")
Text Mining - Techniques & Limitations (A Pharmaceutical Industry Viewpoint)Frank Oellien
Presentation given at the 6th and last meeting of the European Commission "Licenses for Europe" Text and Data Mining Working Group (WG4).
The first part of the talk gives a very brief introduction of some basic concepts of text mining techniques used in Pharmaceutical industry using the Accelrys PP text mining collection.
The second part of the talk focuses on existing limitations pharmaceutical companies are facing in the field of Text mining.
http://ec.europa.eu/licences-for-europe-dialogue/en/content/text-and-data-mining-working-group-wg4
Algorithmen und Applikationen zur interaktiven Visualisierung und visuellen D...Frank Oellien
Algorithmen und Applikationen zur interaktiven Visualisierung und visuellen Data Mining chemiespezifischer Datensätze, Intervet, 2002, Schwabenheim, Germany
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
2. Background / Motivation
Former Bioinformatics Software
• Metalife BioInformatics Suite
• Client-Server application
• Tools for expert users & non-specialists
• Highly customized (developed with Intervet)
• Large, complex Microsoft SQL Server backend (specific stores)
• Globally used in SP animal health by expert users and lab scientists
Reasons for Change
• SP / OBS Merger: Software Consolidation
• Limitations in Metalife
– Database Updates (time-consuming, complex)
– Enhancements (too few, takes too long)
• Pipeline Pilot was already used in our group since one year
SP Intervets BioInformatics Portal
10/16/2009
2
3. Requirements for PP Solution
• Application-like instead of Web-Service like
• Meet user expectations / similar to former solution
– Usability
– Functionality
•
•
•
•
•
Easy to use for non-specialist lab scientists
Sufficient capabilities for expert users
Flexible (allow fast response on changed user requirements)
User context instead of job context
Allow combination with other software packages and databases
SP Intervets BioInformatics Portal
10/16/2009
3
4. Default Pipeline Pilot Webport
• Standard customization options available
– Not enough, do not meet our requirements
SP Intervets BioInformatics Portal
10/16/2009
4
5. BioInformatics Portal
Re-designed webport
(header & navigation)
New starting window
All protocols can be
accessed depending
on the user dataset
(nucleotide, protein)
SP Intervets BioInformatics Portal
10/16/2009
5
6. Job Context versus User Context
New User folder window
• Windows Explorer-like
• based on PP file chooser
framework
All protocols write
PDF reports that are
stored in the corresponding
subfolders
SP Intervets BioInformatics Portal
10/16/2009
6
7. Example Workflow (BLASTn) - Input
Presentation according
Schering-Ploughs corporate
identity
→ using HTML attribute of
reporting components and
standard includes
but also limitations!
Not static!
Information will be retrieved
during protocol execution
(e.g. database access)
Presentation follows the
representation and
functionality of the NCBI
Web-services
→ critical !!!
SP Intervets BioInformatics Portal
10/16/2009
7
8. Example Workflow (BLASTn) – Results I
Summary View
Several Limitations:
1. Custom CSS styles can not
be defined to influence
the table design
2. The Link-Webport Issue
SP Intervets BioInformatics Portal
10/16/2009
8
10. Example Workflow (BLASTn) – Results II
Detail View
External Links
Formatted Alignment
SP Intervets BioInformatics Portal
10/16/2009
10
11. Example Workflow (BLASTn) – Results II
Detail View
External Links
Formatted Alignment
SP Intervets BioInformatics Portal
10/16/2009
11
12. Example Workflow (BLASTn) – Results II
Detail View
External Links
Formatted BioInfPortal_SystemDatabases.xls
Alignment
SP Intervets BioInformatics Portal
10/16/2009
12
13. Example Workflow (BLASTn) – Results III
Result Refinement
Postfilter Tool
SP Intervets BioInformatics Portal
10/16/2009
13
14. Example Workflow (BLASTn) – Results III
Result Refinement
Postfilter Tool
SP Intervets BioInformatics Portal
10/16/2009
14
15. Example Workflow (BLASTn) – Results III
Result Refinement
Postfilter Tool
SP Intervets BioInformatics Portal
10/16/2009
15
16. Example Workflow (BLASTn) – Results III
Result Refinement
Postfilter Tool
SP Intervets BioInformatics Portal
10/16/2009
16
17. Example Workflow (BLASTn) – Results IV
PDF Reports
Remember the User Context
var url = "/scitegic-bin/DownloadFile?SID=" + sessionid + "&filename=" + uripath;
var w = window.open(url, "_blank", "status=yes,rezizable=yes,location=no");
SP Intervets BioInformatics Portal
10/16/2009
17
19. Upload of User Datasets
SP Intervets BioInformatics Portal
10/16/2009
19
20. Automatic Database Update
Processing and indexing
Scheduled download of FASTA databases from
NCBI (Genbank), Expasy (Uniprot), and RCSB
(PDB) via FTP
SP Intervets BioInformatics Portal
10/16/2009
20
21. Technical Details
Productive System
• Dell Power Edge 2950 Server
• 8 Intel Xeon X5355 CPUs, 2.66 GHz
• 32 GB RAM
• 100 GB Swap Space
• Storage:
–
–
–
–
Dell EMC CX700 (Clarion) SAN
3,6 TB
2 redundant controller
8-way FC connection
• RedHat Enterprise Linux 5.3
Development System
• Dell Precision T5400 Desktop
• 8 Intel Xeon E5405 CPUs, 2.00 GHz
• 16 GB RAM
• 20 GB Swap Space
• Storage:
– SGI TPS9300 Raid System
(our common working raid, NFS)
– 3,4 TB
• RedHat Enterprise Linux 5.4
• Also used for all other PP runs
SP Intervets BioInformatics Portal
10/16/2009
21
22. Outlook: BioInformatics Portal 2.0
• Implementation of additional bioinformatics algorithms
– EMBOSS
– Blast2sequences
• Protein Annotation Workflow
• Enhanced Explorer Functionality
– Drag & Drop
– Copy, Move, Rename, Delete of folders and files
– Context Menu (right mouse button)
• Enhanced Database functionality
– Import of genomes
– Advanced search functionalities
SP Intervets BioInformatics Portal
10/16/2009
22
23. Other Current Developments
Porting our Genlight software to PP
• Tool for genome comparison
• Developed by Intervet and university of Bielefeld
• recently used to identify new
drug targets for Schistosomasis
Journal of Integrative Bioinformatics Yearbook 2004,
ISBN 3-88579-127-7, 2004, 79-94
SP Intervets BioInformatics Portal
10/16/2009
23
24. Other Current Developments
Porting our Genlight software to PP
• Tool for genome comparison
• Developed by Intervet and university of Bielefeld
• recently used to identify new
drug targets for Schistosomasis
Schistosoma
mansoni
Drosophila
Caenorhabditis
melanogaster
elegans
SP Intervets BioInformatics Portal
10/16/2009
24
25. Other Current Developments
Porting our Genlight software to PP
• Tool for genome comparison
• Developed by Intervet and university of Bielefeld
• recently used to identify new
drug targets for Schistosomasis
Potential Target
Schistosoma
associated to
severe Phenotype
mansoni
Drosophila
Caenorhabditis
melanogaster
elegans
SP Intervets BioInformatics Portal
10/16/2009
25
26. Other Current Developments
Porting our Genlight software to PP
• Tool for genome comparison
• Developed by Intervet and university of Bielefeld
• recently used to identify new
drug targets for Schistosomasis
Isentris Integration
• Database Synchronization
• Structure Registration
• Property Calculations
SP Intervets BioInformatics Portal
10/16/2009
26
27. Summary
Integrated bioinformatics suite based
on Pipeline Pilot webport
• Usage of build-in functionalities (CSS)
• Self-developed enhancements (html
and webport Javascript framework)
• Additional functionalities by using
‘hidden’ PP functionalities
Full replacement of former
application framework
• Easy to use for lab scientists
• Powerful enough for expert users
Very flexible and extendable
Further applications will be ported to
PP-based solutions
SP Intervets BioInformatics Portal
10/16/2009
27
28. Acknowledgement
Pedro Gomez Fabre
Scott Markel
Accelrys Support Team
Andreas Rohwer
Richard J. Marhöfer
Hon Tran
Andreas Krasky
Paul M. Selzer
SP Intervets BioInformatics Portal
10/16/2009
28